Chart
| Dec 11, 2024
Source: Dentsu
Chart
| Dec 11, 2024
Source: Dentsu
We list the key takeaways from EY’s survey of Gen Zers.
Article
| Apr 3, 2025
Here are five charts on the size of and outlook for the B2B digital ad market worldwide and in 13 individual countries.
Report
| Nov 1, 2024
Burberry will cut 20% of global workforce as sales slump continues: The company’s ill-timed brand elevation push puts it in a difficult position to weather luxury headwinds.
Article
| May 14, 2025
Back-to-school sales will decelerate this year: Mounting macroeconomic pressures are prompting retailers to kick off promotions earlier and encouraging consumers to buy now rather than later.
Article
| Jun 9, 2025
On Running leans into premiumization to offset tariff impact: The company plans to raise prices as enthusiasm for its expensive sneakers remains high.
Article
| May 13, 2025
The news: Gander Social is an upcoming Canadian social platform built on the decentralized AT Protocol, similar to Bluesky. Gander rejects algorithmic feeds, ad surveillance, and dark UX patterns, per Metricool.
As an alternative to networks like X, Meta’s Threads, and Bluesky, it offers user-controlled content, privacy by design, and community-first tools—hosted entirely within Canada. It will be available as a closed beta in August.
Our take: As algorithmic fatigue and platform distrust grow, demand is rising for community-driven, ad-light spaces. Marketers should watch Gander as a testbed for the next wave of privacy-first, hyper-local platforms.
Article
| Jul 3, 2025
US tariffs could stall Germany’s economy this year: GDP is forecast to grow just 0.1% as the duties on autos and other imports curb companies’ access to an important growth market.
Article
| Apr 10, 2025
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Forecasts
| Jan 30, 2024
Source: Ä¢¹½AV Forecast
Drug developers relocate clinical trials amid Trump’s NIH research and funding cuts: The final damage to research pipelines is still to be determined, but biotech and pharma companies are already reacting, and more may consider doing so given the uncertainty.
Article
| May 16, 2025